Outcomes for ESD of Pathologically Staged T1b Esophageal Cancer: A Multi-Center Study
Abel Joseph,Peter V Draganov,Fauze Maluf-Filho,Hiroyuki Aihara,Norio Fukami,Neil R Sharma,Amitabh Chak,Dennis Yang,Salmaan Jawaid,John Dumot,Omar Alaber,Tiffany Chua,Rituraj Singh,Lady Katherine Mejia-Perez,Ruishen Lyu,Xuefeng Zhang,Suneel Kamath,Sunguk Jang,Sudish Murthy,John Vargo,Amit Bhatt,Peter Draganov,Neil R. Sharma,Salman Jawaid
DOI: https://doi.org/10.1016/j.gie.2022.02.018
IF: 10.396
2022-02-01
Gastrointestinal Endoscopy
Abstract:Background & AimsThe outcomes of endoscopic submucosal dissection (ESD) for T1b esophageal cancer and its recurrence rates remain unclear in the west. Using a multicenter cohort, we evaluated technical outcomes and recurrence rates of ESD in the treatment of pathologically staged T1b esophageal cancer (EC).MethodsWe included patients who underwent ESD of T1b EC at seven academic tertiary referral centers in the USA (n=6) and Brazil (n=1). We analyzed demographic, procedural, histopathologic characteristics, and follow-up data. Time-to-event analysis was performed to evaluate recurrence rates.ResultsSixty-six patients with pathologically staged T1b EC after ESD were included in the study. The pre-procedure staging EUS was available in 54 patients. The pre-procedure EUS staging was Tis/T1a in twenty-seven of fifty-four (50%) of patients and T1b in twenty-seven of fifty-four (50%) of patients. En-bloc resection rate was 92.4% (61/66), R0 resection rate was 54.5% (36/66). Forty-nine of sixty-six (74.2%) of patients did not undergo surgery immediately after resection and went on to surveillance. Ten patients had ESD resection within curative criteria, and no recurrences were seen in a 13 month [3-18.5] follow-up period in these patients. Ten of thirty-nine (25.6%) patients with non-curative resections had residual/recurrent disease. Local recurrence alone was seen in five of thirty-nine (12.8%) patients with non-curative resection and metastatic recurrence in five of thirty-nine (12.8%) patients with non-curative resection. On univariate analysis, R1 resection had a higher risk of recurrent disease (HR 6.25 (1.29, 30.36), p-value 0.023)ConclusionEUS staging of T1b of EC has poor accuracy and staging ESD should be considered in these patients. ESD R0 resection rates are low in T1b EC, and R1 resection is associated with recurrent disease. Patients with non-curative ESD resection of T1b who cannot undergo surgery should be surveyed closely, as recurrent disease was seen in 25% of these patients.
gastroenterology & hepatology